Jones Financial Companies’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.1K Buy
1,276
+453
+55% +$6.47K ﹤0.01% 3664
2026
Q1
$14.5K Sell
823
-374
-31% -$6.69K ﹤0.01% 3432
2025
Q4
$19.2K Sell
1,197
-164
-12% -$2.44K ﹤0.01% 2942
2025
Q3
$17.4K Sell
1,361
-2,451
-64% -$28.7K ﹤0.01% 2865
2025
Q2
$44.8K Sell
3,812
-11,672
-75% -$138K ﹤0.01% 2267
2025
Q1
$237K Sell
15,484
-899
-5% -$15.1K ﹤0.01% 1429
2024
Q4
$284K Buy
16,383
+1,569
+11% +$30.3K ﹤0.01% 1199
2024
Q3
$271K Buy
14,814
+4,514
+44% +$90.6K ﹤0.01% 1037
2024
Q2
$209K Buy
+10,300
New +$182K ﹤0.01% 823
2022
Q1
Sell
-92
Closed -$2K 708
2021
Q4
$2K Buy
+92
New +$2.4K ﹤0.01% 715
2013
Q4
Sell
-11
Closed -$2K 277
2013
Q3
$2K Hold
11
﹤0.01% 646
2013
Q2
$2K Buy
+11
New +$1.56K ﹤0.01% 723

Other funds holding CLB

Jones Financial Companies's CLB Position: Q2 2026 in Review

Jones Financial Companies increased its Core Laboratories (CLB) stake by 55% in Q2 2026, buying an estimated $6.47K and bringing the position to 1,276 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3664.

Jones Financial Companies first reported a position in CLB in Q2 2013 and has held it in 12 quarters since. The position peaked at $284K in Q4 2024. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Jones Financial Companies held 1,276 shares of Core Laboratories worth $14.1K as of Q2 2026.
  • Jones Financial Companies bought 453 Core Laboratories shares in Q2 2026, an estimated $6.47K.
  • Core Laboratories made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3664 holding.
  • Jones Financial Companies first reported a position in Core Laboratories in Q2 2013 and has held it in 12 quarters since.
  • Jones Financial Companies's Core Laboratories position peaked at $284K in Q4 2024.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.